dr reddy glp 1 With the launch of our oral semaglutide biosimilar, Obeda® tablets, we are broadening our GLP‑1 portfolio to offer more choice and flexibility for patients. Oral semaglutide, as a convenient and flexible option 1 journey with Side Effect Relief Dr. Reddy's Unveils Obeda® Semaglutide

Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease

While most were developed to treat type 2 diabetes, many have subsequently been found to offer health benefits for people with obesity and cardiovascular disease, and to reduce the risk of kidney failure in people with and without diabetes

doi: 10.1136/jnnp-2017-316194 117

Brain Res 1752:147230 Tan CC, Zhang JG, Tan MS et al (2015) NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model [J]

Glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists reduce body weight, glycaemia, blood pressure, postprandial lipaemia and infammation actions that could contribute to the reduction of cardiovascular events

Peptides are long, delicate chains of amino acids